Showing results (2941-2950 of 6,181) with videos related to
Sort By:
Pageof 619
Nature Medicine|March 27, 2024
Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular diseaseAnubha Agarwal, Priya M Mehta, Tyler Jacobson, et al.Nature Medicine|April 11, 2024
Feasibility of functional precision medicine for guiding treatment of relapsed or refractory pediatric cancersArlet M Acanda De La Rocha, Noah E Berlow, Maggie Fader, et al.Nature Medicine|April 8, 2024
Continuous glucose monitoring and intrapersonal variability in fasting glucoseSmadar Shilo, Ayya Keshet, Hagai Rossman, et al.Nature Medicine|January 24, 2024
T cell lymphoma and secondary primary malignancy risk after commercial CAR T cell therapyGuido Ghilardi, Joseph A Fraietta, James N Gerson, et al.Nature Medicine|February 5, 2024
Closing the accessibility gap to mental health treatment with a personalized self-referral chatbotJohanna Habicht, Sruthi Viswanathan, Ben Carrington, et al.Nature Medicine|September 3, 2024
Integrating liver endpoints in clinical trials of cardiovascular and kidney diseaseFaiez Zannad, Arun J Sanyal, Javed Butler, et al.Nature Medicine|September 3, 2024
Fratricide-resistant CD7-CAR T cells in T-ALLBernice L Z Oh, Noriko Shimasaki, Elaine Coustan-Smith, et al.Nature Medicine|August 30, 2024
Unidirectional association of clonal hematopoiesis with atherosclerosis developmentMiriam Díez-Díez, Beatriz L Ramos-Neble, Jorge de la Barrera, et al.Nature Medicine|September 1, 2024
Finerenone in heart failure and chronic kidney disease with type 2 diabetes: FINE-HEART pooled analysis of cardiovascular, kidney and mortality outcomesMuthiah Vaduganathan, Gerasimos Filippatos, Brian L Claggett, et al.Nature Medicine|September 14, 2024
Datopotamab-deruxtecan plus durvalumab in early-stage breast cancer: the sequential multiple assignment randomized I-SPY2.2 phase 2 trialRebecca A Shatsky, Meghna S Trivedi, Christina Yau, et al.Pageof 619